Currency In USD
| Previous Close | 2.34 |
| Open | 2.38 |
| Day High | 2.38 |
| Day Low | 2.2 |
| 52-Week High | 3.44 |
| 52-Week Low | 0.8 |
| Volume | 1.29M |
| Average Volume | 2.11M |
| Market Cap | 154.48M |
| PE | -5.05 |
| EPS | -0.44 |
| Moving Average 50 Days | 2.68 |
| Moving Average 200 Days | 1.82 |
| Change | -0.12 |
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire Inc.
Mar 03, 2026 1:30 PM GMT
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the li
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire Inc.
Feb 10, 2026 9:34 PM GMT
All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro forma basisFull year 2025 revenu
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 20, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the live